3SBio Inc. (OTCMKTS:TRSBF – Get Free Report) was the target of a significant growth in short interest in July. As of July 15th, there was short interest totaling 14,802,882 shares, a growth of 142.1% from the June 30th total of 6,115,388 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.
3SBio Price Performance
Shares of 3SBio stock opened at $2.15 on Tuesday. The company has a fifty day moving average of $2.26 and a 200 day moving average of $2.67. 3SBio has a fifty-two week low of $2.00 and a fifty-two week high of $4.74.
About 3SBio
3SBio Inc (OTCMKTS: TRSBF) is a China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of protein-based therapeutics and chemical drugs. Established in 1999 and headquartered in Shenyang, Liaoning Province, the company has built an integrated platform that encompasses in-house R&D capabilities, clinical development, commercial production and a nationwide sales network.
The company’s product portfolio features a range of hematopoietic growth factors such as recombinant human granulocyte colony-stimulating factor (rhG-CSF) and recombinant human erythropoietin (rhEPO), insulin and insulin analogs, hemostasis agents and monoclonal antibodies.
Further Reading
- Five stocks we like better than 3SBio
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Receive News & Ratings for 3SBio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 3SBio and related companies with MarketBeat.com's FREE daily email newsletter.
